- Conditions
- Attention Deficit Hyperactivity Disorder, Executive Dysfunction
- Interventions
- Homework, Organization, and Planning Skills
- Behavioral
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 11 Years to 15 Years
- Enrollment
- 240 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2027
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
Institution Directory
Clinical trials at Children's Hospital of Philadelphia
Sites in Philadelphia, PA
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
601
Shown on this page
12
Current sort
Recently updated
Campus scope
Children's Hospital of Philadelphia, Philadelphia, PA
Additional filters apply within this campus.
The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.
Showing 445–456 of 601 matching trials with a site at Children's Hospital of Philadelphia, Philadelphia, PA.
Indexed local directory records.
Stored official records
- Conditions
- Renal Tumor, Wilms Tumor
- Interventions
- Proton beam radiation using pencil beam scanning
- Other
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 0 Years to 30 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2028
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH
NCT03107520
Status at this site: Recruiting
- Conditions
- Developmental Dysplasia of the Hip
- Interventions
- Intraoperative contrast-enhanced ultrasound (CEUS), Lumason
- Diagnostic Test · Drug
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 4 Months to 24 Months
- Enrollment
- 125 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2030
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
Reducing Antibiotic Use by Implementation of Stewardship in Primary and Urgent Care
NCT07217002
Site status not listed — check the official record
- Conditions
- Acute Otitis Media (AOM), Community Acquired Pneumonia (CAP), Sinusitis, Strep Pharyngitis
- Interventions
- Clinical Decision Support, Live, hybrid in-person and online educational sessions, Online Educational Modules, Prescribing Feedback Reports
- Other
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 6 Months to 12 Years
- Enrollment
- 420 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
Trial of a Nurse-Led Firearm Safety Intervention in the Pediatric Inpatient Setting
NCT07501247
Site status not listed — check the official record
- Conditions
- Firearm Injury, Firearm Safety, Suicide
- Interventions
- Adapted S.A.F.E. Firearm, Implementation bundle
- Behavioral
- Lead sponsor
- University of Pennsylvania
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 7,200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 2
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Congenital Heart Disease, Single-ventricle
- Interventions
- Digital Exercise Intervention
- Behavioral
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 10 Years to 17 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Type 1 Diabetes
- Interventions
- TZIELD (teplizumab-mzwv)
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- Not listed
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2037
- U.S. locations
- 37
- States / cities
- Los Angeles, California • San Francisco, California • Aurora, Colorado + 32 more
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
NCT01656603
Status at this site: Recruiting
- Conditions
- Infusion Reactions
- Interventions
- unlicensed CBU
- Biological
- Lead sponsor
- New York Blood Center
- Other
- Eligibility
- Not listed
- Enrollment
- 9,999 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2030
- U.S. locations
- 71
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 53 more
- Conditions
- Becker's Muscular Dystrophy (BMD), Duchenne Muscular Dystrophy (DMD)
- Interventions
- Descending stair walk
- Other
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 2 Years to 10 Years · Male only
- Enrollment
- 50 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures
NCT04604418
Status at this site: Recruiting
- Conditions
- Congenital Heart Disease in Children
- Interventions
- No intervention. It is observational
- Other
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- Up to 21 Years
- Enrollment
- 10,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2026
- U.S. locations
- 9
- States / cities
- Los Angeles, California • Washington D.C., District of Columbia • Atlanta, Georgia + 6 more
- Conditions
- Accident, Traffic, Development, Adolescent, Injuries, Risk Reduction Behavior
- Interventions
- Behind-the-Wheel Driver Training, Online Driver Skills Training, Online Vehicle and Driver Safety Education
- Behavioral
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 16 Years to 17 Years
- Enrollment
- 1,300 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations
NCT06653842
Site status not listed — check the official record
- Conditions
- Cutaneous Venous Malformations
- Interventions
- QTORIN 3.9% rapamycin anhydrous gel
- Drug
- Lead sponsor
- Palvella Therapeutics, Inc.
- Industry
- Eligibility
- 6 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 10
- States / cities
- Irvine, California • Palo Alto, California • Aurora, Colorado + 7 more
About this Children's Hospital of Philadelphia institution page
- What this page lists
- ClinicalTrials.gov records that list Children's Hospital of Philadelphia in Philadelphia, PA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
- Site status
- A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
- Where the data comes from
- Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
- What this page does not do
- No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages, browse by condition, or browse by U.S. city.